GlassScriptPhysician profile
Wesley Carroll Chambers
NPI 1588984090
$1,228.68
in general payments reported to CMS, 2019-2025
20 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $139 · 2021: $303 · 2022: $318 · 2023: $15.48 · 2024: $106 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $332.09 | 2019-2022 | |
| Hologic Sales and Service, LLC | $307.14 | 2019-2022 | |
| Evofem Biosciences, INC. | $86.05 | 2021-2022 | |
| Biogen, INC. | $67.80 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $51.79 | 2019-2020 | |
| Myovant Sciences INC. | $45.31 | 2021-2022 | |
| Optumhealth Care Solutions, LLC | $44.93 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Medtronic, INC. | $43.91 | 2024 | Interstim |
| Scynexis, INC. | $36.89 | 2022 | |
| Sumitomo Pharma America, INC. | $32.83 | 2023-2024 | Myfembree |
| Roche Diagnostics Corporation | $27.00 | 2019 | |
| Acessa Health INC. | $22.47 | 2020 | |
| Pfizer INC. | $22.36 | 2022 | |
| Organon LLC | $20.55 | 2025 | Jada System, Nexplanon |
| Mimedx Group, INC. | $17.76 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $17.59 | 2021 | |
| Medline Industries LP | $14.61 | 2022 | |
| Baxter Healthcare | $14.05 | 2022 | |
| Minerva Surgical, INC | $11.87 | 2022 | |
| Amag Pharmaceuticals, INC. | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Chambers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.